Technology and Life Sciences
New tech and life sciences companies can grow quickly and reach very high valuations. We work with them from launch to exit, to increase the chances of success and enable everyone involved to fully reap the benefits.
With great vision, sound judgement, the right financing, hard work and, on occasion, some good fortune, a tech start-up can define a new business segment or develop a new foundational technology; and a life sciences business can develop a cutting-edge therapy or a new category of medical device.
We’ve been involved in advising tech and life sciences companies for decades – including pioneers in software development, AI, data science, SAAS offerings, video games or other digital media, semi-conductor or optoelectronics/laser design, drug discovery, biotech research, medical device development, pharmaceutical marketing, and much else besides. They range from the earliest start-ups (including many that have raised significant VC rounds before successful liquidity events, and Scotland’s first unicorn), to large international corporates (helping many of them with acquisitions of UK tech/life sciences businesses).
We are also an active part of the entrepreneurial ecosystem through a number of pro bono mentoring arrangements and our work with various incubators and accelerators.
Scotland’s deep research base generates a diverse range of technology and life sciences innovations, and our clients have been active across the breadth of that research and development – including in drug discovery, medical device development, specialty pharmaceuticals, semiconductor design, battery tech development, optoelectronics and laser devices, codec technologies, AI, data science, network and cyber security and video games and other digital media. We bring to bear our experience in all these sectors to help our clients accomplish their goals.
Our lawyers understand the commercial drivers of technology and life sciences businesses and have the experience to foresee potential issues before they arise – because we succeed when our clients do, and we have a decades-long track record of helping our clients to do so.
Our expertise includes:
- Start-ups, scale-ups and venture capital
- Private equity
- Mergers and acquisitions
- Collaborations and joint ventures
- Corporate tax
- Equity incentives
- Employment and immigration
- Data protection and privacy
- Intellectual property and brand protection
- R&D arrangements, clinical trial agreements and technology transfers
- Competition and regulatory advice
- Commercial contracts
- All other “go to market” matters
We have expertise in all areas of technology and life sciences, including:
Related articles and insights: Technology and Life Sciences
10 December 2025
EMI options – How to get them right
Contributor: Gavin Charlton
Following the expansion of qualifying companies for EMI options in the Autumn Budget we look at the most common mistakes made when implementing an EMI plan and how businesses can avoid them.
Contact us